Superselective ophthalmic artery thrombolysis for central retinal artery occlusion

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500100810

Enrollment

Unknown

Registered

2025-04-15

Start date

2025-05-01

Completion date

Unknown

Last updated

2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central retinal artery occlusion

Interventions

Thrombolysis group:Superselective ophthalmic artery thrombolysis

Control group:Conservative treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with clinical diagnosis of central retinal artery occlusion.

Exclusion criteria

Exclusion criteria: 1: History of panretinal laser photocoagulation or anti-vascular endothelial growth factor therapy, and other types of intraocular surgery; 2: History of ocular trauma; 3: With other retinal/choroidal diseases, age-related macular degeneration, vitreoretinal traction, epiretinal membrane, macular hole or uveitis, etc. 4: Poor WSS-OCTA image quality in both eyes and poor patient compliance.

Design outcomes

Primary

Measure	Time frame
Vision;Retinal thickness;	—

Secondary

Measure	Time frame
Retinal blood flow;	—

Countries

China

Contacts

Public ContactHuadong Lou

Qingdao Eighth People’s Hospital

qdbylhd@163.com+86 157 5329 5360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026